국가: 오스트레일리아
언어: 영어
출처: Department of Health (Therapeutic Goods Administration)
gentamicin, Quantity: 80 mg
Pfizer Australia Pty Ltd
Gentamicin
Injection, solution
Excipient Ingredients: sulfuric acid; water for injections; sodium hydroxide; disodium edetate
Intravenous, Intramuscular
2mL x 10, 2mL x 50
(S4) Prescription Only Medicine
Indications as at November 2000; For the treatment of infections due to one or more susceptible strains of bacteria, including Pseudomonas aeruginosa, Proteus species (indole positive and indole negative), Escherichia coli, Klebsiella, Enterobacter and Serratia species and Staphylococcus (including strains resistant to other antibiotics). Gentamicin may also be used for the treatment of the following conditions when caused by susceptible organisms: bacteraemia, respiratory tract infections, urinary tract infections, skin and skin structure infections, bone infections, peritonitis, septic abortion and burns complicated by sepsis. Aminoglycosides, including gentamicin are generally not indicated in uncomplicated initial episodes of urinary tract infection unless the causative organisms are not susceptible to less toxic antibiotics. In suspected or documented Gram-negative sepsis, gentamicin should be considered for initial antimicrobial therapy. Therapy may be instituted before obtaining results of susceptibi
Visual Identification: Clear, pale yellow, sterile aqueous solution.; Container Type: Ampoule; Container Material: LDPE; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius
Registered
1991-08-13
GENTAMICIN INJECTION CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Gentamicin Injection. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have benefits and risks. Your doctor has weighed the risks of you taking Gentamicin Injection against the benefits this medicine is expected to have for you. This medicine is likely to be used while you are at the clinic or in hospital. If possible, please read this leaflet carefully before this medicine is given to you. In some cases this leaflet may be given to you after the medicine has been used. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. WHAT GENTAMICIN INJECTION IS USED FOR Gentamicin Injection belongs to a group of medicines known as aminoglycoside antibiotics. Aminoglycoside antibiotics work by preventing bacteria from growing and by killing them. Gentamicin Injection is used to treat serious bacterial infections in many different parts of the body such as chest infections, urinary tract infections and infected wounds or burns. Gentamicin Injection may be prescribed for other reasons that are not mentioned above. Your doctor will be able to tell you about the specific condition for which you have been prescribed it. This medicine is available only with a doctor's prescription. BEFORE YOU ARE GIVEN GENTAMICIN INJECTION _WHEN YOU MUST NOT BE GIVEN_ _IT_ DO NOT USE GENTAMICIN INJECTION IF: • you have an allergy to gentamicin or any of the ingredients listed at the end of this leaflet • you have an allergy to other aminoglycoside antibiotics such as tobramycin, streptomycin, amikacin, netilmicin or neomycin If you are not sure whether any of these apply to you, check with your doctor. _BEFORE YOU ARE GIVEN IT_ TELL YOUR DOCTOR IF: 1. YOU HAVE ANY ALLERGIES TO: • any other medicine • any other substances, such as foods, preservatives or dy 전체 문서 읽기
Version: pfpgenai10220 Supersedes: pfpgenai10311 Page 1 of 12 AUSTRALIAN PRODUCT INFORMATION – GENTAMICIN INJECTION BP (GENTAMICIN SULFATE) 1. NAME OF THE MEDICINE Gentamicin sulfate 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Gentamicin Injection BP is a sterile, preservative-free solution containing Gentamicin (as Sulfate) 80 mg/2 mL. 3. PHARMACEUTICAL FORM Solution for injection. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the treatment of infections due to one or more susceptible strains of bacteria, including _Pseudomonas aeruginosa_, Proteus species (indole positive and indole negative), _Escherichia_ _coli_, Klebsiella, Enterobacter and Serratia species and Staphylococcus (including strains resistant to other antibiotics). Gentamicin may also be used for the treatment of the following conditions when caused by susceptible organisms: bacteraemia, respiratory tract infections, urinary tract infections, skin and skin structure infections, bone infections, peritonitis, septic abortion and burns complicated by sepsis. Aminoglycosides, including gentamicin are generally not indicated in uncomplicated initial episodes of urinary tract infection unless the causative organisms are not susceptible to less toxic antibiotics. In suspected or documented Gram-negative sepsis, gentamicin should be considered for initial antimicrobial therapy. Therapy may be instituted before obtaining results of susceptibility tests. The decision to continue therapy is based on results of the susceptibility tests, the severity of the infection and risk of toxicity. If anaerobic organisms are suspected, antimicrobial therapy in addition to the gentamicin regimen should be considered. 4.2 DOSE AND METHOD OF ADMINISTRATION EACH AMPOULE IS FOR USE IN A SINGLE PATIENT ON ONE OCCASION ONLY Gentamicin is normally given by intramuscular injection. Intravenous administration may be used for particular indications when the intramuscular route is not appropriate. The dosage is Version: pfpgenai10220 Supersedes: pfpgenai10311 Page 2 of 전체 문서 읽기